Avella of Deer Valley, Inc. Store 38 recalls BEVACIZUMAB 2.5 MG/0.1ML, pre-filled syringe (deliverable dose of 1.25MG in normject syringe) Repackaged by Avella
Avella recalls specific BEVACIZUMAB 2.5 MG/0.1ML pre-filled syringes due to lack of sterility assurance. Affected units have NDC 42852-001-24 and lot # 138-20182408@58. Consumers should contact Avella for details.
Recall notice
Lack of Assurance of Sterility
Contact the company & request your remedy
What happened, in plain English
Avella is recalling certain BEVACIZUMAB 2.5 MG/0.1ML pre-filled syringes because they may not be sterile. This could lead to infections if used improperly. The recall affects patients receiving this medication through Avella Specialty Pharmacy. Read more at govinfonow.com/recall/39459-avella-bevacizumab-2-5-mg-0-1ml-syringes-recall-lack.
Source Summary by GovInfoNow · govinfonow.com/recall/39459-avella-bevacizumab-2-5-mg-0-1ml-syringes-recall-lack · Updated October 5, 2026 · FDA enforcement record: FDA #D-0224-2019
Cite this page
“Avella BEVACIZUMAB 2.5 MG/0.1ML Syringes Recall: Lack of Sterility Assurance.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39459-avella-bevacizumab-2-5-mg-0-1ml-syringes-recall-lack. Based on FDA recall #D-0224-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0224-2019%22&limit=1).
Why it’s dangerous
The syringes lack assurance of sterility, meaning they might contain contaminants that could cause infections when injected. This is a serious risk for patients using the medication.
Who’s affected
Patients receiving BEVACIZUMAB 2.5 MG/0.1ML injections through Avella Specialty Pharmacy are affected. Those with the specific NDC and lot numbers are most at risk.
How to tell if you have this one
Check for the NDC code 42852-001-24 and lot number 138-20182408@58 on the syringe label. These syringes were repackaged by Avella Specialty Pharmacy in Phoenix, Arizona.
- Brand
Avella- Category
Drug
What to do — step by step
Contact Avella
Reach out to Avella Specialty Pharmacy at 24416 N 19th Avenue, Phoenix, AZ 85085 for assistance with the recall.
Questions people ask
What is the specific product being recalled?
The recalled product is BEVACIZUMAB 2.5 MG/0.1ML pre-filled syringes with NDC 42852-001-24 and lot # 138-20182408@58.
How can I check if I have the recalled product?
Look for the NDC code 42852-001-24 and lot number 138-20182408@58 on the syringe label.
What should I do if I have the recalled product?
Contact Avella Specialty Pharmacy at 24416 N 19th Avenue, Phoenix, AZ 85085 for instructions.
Contact Avella
We’ve drafted a message you can send Avella to request your refund or repair — edit it as you like.
Subject: Recall D-0224-2019 — Avella Avella Hello, I own a Avella that is covered by recall D-0224-2019 from Avella. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0224-2019 (October 31, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0224-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.